비교리스트

 카트 문의
시장보고서
상품코드
1652030

세계의 코로나19 진단 시장 : 시장 규모, 점유율 및 동향, 업계 분석 - 제품 유형별, 시료 유형별, 검사 유형별, 지역별, 예측(2025-2034년)

COVID-19 Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product Type, Sample Type, Test Type, and Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 코로나19 진단 시장 규모는 2034년까지 72억 6,000만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

코로나19 진단 시장 수요 증가는 세계 아웃 브레이크 관리를 위한 효과적인 검사 솔루션의 필요성, 신속하고 정확한 검사에 대한 높은 수요, 검사 능력을 높이기 위한 정부의 이니셔티브, 진단 기술의 발전으로 인한 것입니다. 가정용 검사 키트의 채용 확대, 진단 향상을 위한 AI와 디지털 플랫폼의 통합, 여러 감염증을 한 번에 검출할 수 있는 멀티플렉스 검사의 개발 등에 성장 기회가 존재합니다.

PoC(Point of Care) 검사와 신형 바이러스 검출에 대한 주력 증가 등 코로나19 진단 시장의 새로운 동향이 시장을 형성하고 있습니다. 전반적으로 정부, 의료기관, 소비자들이 팬데믹과 싸우고 향후 건강 문제에 대비하기 위해 효율적이고 사용하기 쉬우며, 확장 가능한 검사 솔루션을 찾고 있기 때문에 시장은 지속적으로 성장할 태세를 갖추고 있습니다.

코로나19 진단 시장 : 분석 개요

제품 유형별로는 시약 및 키트 부문이 코로나19 진단 시장 수익의 최대 점유율을 차지하고 있으며, 특히 PCR 검사 및 신속 항원 검사 등 광범위한 검사에 필수적인 역할을 담당하고 있습니다. 장비 분야는 자동 진단 시스템의 발전과 높은 처리량 검사 솔루션 수요 증가에 힘입어 가장 높은 성장을 기록하고 있습니다.

샘플 유형별로 면봉 분야는 코로나19 진단 시장 점유율을 독점하고 있습니다. 특히 임상 및 공중 보건 환경에서 분자 및 항원 검사용 샘플을 채취하는 주요 방법입니다. 혈액 검체 부문이 가장 높은 성장을 이루고 있는데, 이는 주로 감염 후의 감시와 면역 평가를 위한 항체 검사나 혈청 검사의 사용이 증가하고 있기 때문입니다.

분자(RT-PCR) 검사 분야는 활발한 COVID-19 감염을 검출하는 가장 정확한 방법으로 간주되어 시장을 계속 독점하고 있습니다. 그러나 항원 기반 검사 분야는 특히 PoC 및 가정 환경에서 신속한 결과 제공과 사용 편의성이 원동력이 되어 가장 높은 성장을 이루고 있습니다.

북미는 특히 미국에서 견고한 의료 인프라와 높은 검사 수요를 배경으로 가장 큰 시장 점유율을 차지합니다. 아시아태평양은 가장 성장률이 높은 지역이며, PoC 검사 솔루션의 혁신과 함께 인도나 중국과 같은 인구밀도가 높은 국가에서 검사에 대한 대처가 급속히 확대되고 있는 것이 그 요인이 되고 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 분석 방법

제4장 코로나19 진단 시장 인사이트

  • 시장 현황
  • 코로나19 진단 시장 역학
    • 성장 촉진요인 및 기회
      • PoC 검사 솔루션 수요 증가
      • 진단에 있어서 첨단 기술의 통합
      • 재택 검사 키트의 인기
    • 억제요인 및 과제
      • 훈련을 받은 인재의 부족
  • PESTLE 분석
  • 코로나19 진단 시장 동향 : 검사 유형별
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 코로나19 진단 시장 : 제품 유형별

  • 주요 분석 결과
  • 서문
  • 시약 및 키트
  • 장치
  • 기타

제6장 세계의 코로나19 진단 시장 : 시료 유형별

  • 주요 분석 결과
  • 서문
  • 면봉
  • 혈액
  • 기타

제7장 세계의 코로나19 진단 시장 : 검사 유형별

  • 주요 분석 결과
  • 서문
  • 분자(RT-PCR) 검사
  • 항원 검사
  • 항체(혈청학)

제8장 세계의 코로나19 진단 시장 : 지역별

  • 주요 분석 결과
  • 서문
    • 코로나19 진단 시장의 평가 : 지역별(2020-2034년)
  • 북미
    • 북미 : 제품 유형별(2020-2034년)
    • 북미 : 시료 유형별(2020-2034년)
    • 북미 : 검사 유형별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 제품 유형별(2020-2034년)
    • 유럽 : 시료 유형별(2020-2034년)
    • 유럽 : 검사 유형별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 제품 유형별(2020-2034년)
    • 아시아태평양 : 시료 유형별(2020-2034년)
    • 아시아태평양 : 검사 유형별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 제품 유형별(2020-2034년)
    • 중동 및 아프리카 : 시료 유형별(2020-2034년)
    • 중동 및 아프리카 : 검사 유형별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 제품 유형별(2020-2034년)
    • 라틴아메리카 : 시료 유형별(2020-2034년)
    • 라틴아메리카 : 검사 유형별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 사업 확대 및 기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴, 협업, 합의 및 공개

제10장 기업 프로파일

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • BioMerieux
  • PerkinElmer
  • Danaher Corporation
  • Quidel Corporation
  • Hologic
  • Becton Dickinson
  • Cepheid
  • Grifols
  • Stryker Corporation
  • Zhejiang Orient Gene Biotech
  • BGI Genomics
AJY 25.03.12

The global COVID-19 diagnostics market size is expected to reach USD 7.26 billion by 2034, according to a new study by Polaris Market Research. The report "COVID-19 Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product Type (Reagents & Kits, Instruments, and Others), Sample Type, Test Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising COVID-19 diagnostics market demand is attributed to the need for effective testing solutions to manage global outbreaks, high demand for rapid and accurate testing, government initiatives to increase testing capacity, and advancements in diagnostic technologies. Opportunities exist in the growing adoption of at-home testing kits, the integration of AI and digital platforms for improved diagnostics, and the development of multiplex tests that can detect multiple infections at once.

Emerging COVID-19 diagnostics market trends such as point-of-care testing and increasing focus on detecting new virus variants are shaping the market. Overall, the market is poised for continued growth as governments, healthcare organizations, and consumers seek efficient, accessible, and scalable testing solutions to combat the pandemic and prepare for future health challenges.

COVID-19 Diagnostics Market Report Highlights

By product type, the reagents & kits segment holds the largest share of the COVID-19 diagnostics market revenue, driven by their essential role in widespread testing, especially for PCR and rapid antigen tests. The instruments segment is registering the highest growth, fueled by advancements in automated diagnostic systems and increasing demand for high-throughput testing solutions.

Based on sample type, the swabs segment dominates the COVID-19 diagnostics market share. It is the primary method for collecting samples for molecular and antigen tests, particularly in clinical and public health settings. The blood samples segment is experiencing the highest growth, mainly due to the increasing use of antibody and serology tests for post-infection surveillance and immunity assessment.

The molecular (RT-PCR) testing segment continues to dominate the market, regarded as the most accurate method for detecting active COVID-19 infections. However, the antigen-based testing segment is experiencing the highest growth, driven by its rapid result delivery and ease of use, especially in point-of-care and at-home settings.

North America holds the largest market share, with strong healthcare infrastructure and high testing demand, particularly in the US. Asia Pacific is the highest-growing region, driven by the rapid scaling of testing efforts in densely populated countries such as India and China, alongside innovations in point-of-care testing solutions.

Polaris Market Research has segmented the COVID-19 diagnostics market report on the basis of product type, sample type, test type, and region:

By Product Type Outlook (Revenue - USD Billion, 2020-2034)

  • Reagents & Kits
  • Instruments
  • Others

By Sample Type Outlook (Revenue - USD Billion, 2020-2034)

  • Swabs
  • Blood
  • Others

By Test Type Outlook (Revenue - USD Billion, 2020-2034)

  • Molecular (RT-PCR) Testing
  • Antigen-Based Testing
  • Antibody (Serology)

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Covid-19 Diagnostics Market Insights

  • 4.1. Covid-19 Diagnostics Market - Market Snapshot
  • 4.2. Covid-19 Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Point-of-Care Testing Solutions
      • 4.2.1.2. Integration of Advanced Technologies in Diagnostics
      • 4.2.1.3. Growing Popularity of At-Home Testing Kits
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Insufficient Trained Personnel
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Covid-19 Diagnostics Market Test Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Covid-19 Diagnostics Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  • 5.3. Reagents & Kits
    • 5.3.1. Global Covid-19 Diagnostics Market, by Reagents & Kits, by Region, 2020-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Covid-19 Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Covid-19 Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Covid-19 Diagnostics Market, by Sample Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  • 6.3. Swabs
    • 6.3.1. Global Covid-19 Diagnostics Market, by Swabs, by Region, 2020-2034 (USD Billion)
  • 6.4. Blood
    • 6.4.1. Global Covid-19 Diagnostics Market, by Blood, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Covid-19 Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Covid-19 Diagnostics Market, by Test Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
  • 7.3. Molecular (RT-PCR) Testing
    • 7.3.1. Global Covid-19 Diagnostics Market, by Molecular (RT-PCR) Testing, by Region, 2020-2034 (USD Billion)
  • 7.4. Antigen-Based Testing
    • 7.4.1. Global Covid-19 Diagnostics Market, by Antigen-Based Testing, by Region, 2020-2034 (USD Billion)
  • 7.5. Antibody (Serology)
    • 7.5.1. Global Covid-19 Diagnostics Market, by Antibody (Serology), by Region, 2020-2034 (USD Billion)

8. Global Covid-19 Diagnostics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Covid-19 Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Covid-19 Diagnostics Market - North America
    • 8.3.1. North America: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
    • 8.3.3. North America: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.3.4. Covid-19 Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.3.5. Covid-19 Diagnostics Market - Canada
      • 8.3.5.1. Canada: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
  • 8.4. Covid-19 Diagnostics Market - Europe
    • 8.4.1. Europe: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.4. Covid-19 Diagnostics Market - UK
      • 8.4.4.1. UK: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.5. Covid-19 Diagnostics Market - France
      • 8.4.5.1. France: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.6. Covid-19 Diagnostics Market - Germany
      • 8.4.6.1. Germany: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.7. Covid-19 Diagnostics Market - Italy
      • 8.4.7.1. Italy: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.8. Covid-19 Diagnostics Market - Spain
      • 8.4.8.1. Spain: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.9. Covid-19 Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.10. Covid-19 Diagnostics Market - Russia
      • 8.4.10.1. Russia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.4.11. Covid-19 Diagnostics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
  • 8.5. Covid-19 Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.4. Covid-19 Diagnostics Market - China
      • 8.5.4.1. China: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.5. Covid-19 Diagnostics Market - India
      • 8.5.5.1. India: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.6. Covid-19 Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.7. Covid-19 Diagnostics Market - Japan
      • 8.5.7.1. Japan: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.8. Covid-19 Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.9. Covid-19 Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.10. Covid-19 Diagnostics Market - Australia
      • 8.5.10.1. Australia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.5.11. Covid-19 Diagnostics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
  • 8.6. Covid-19 Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.6.4. Covid-19 Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.6.5. Covid-19 Diagnostics Market - UAE
      • 8.6.5.1. UAE: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.6.6. Covid-19 Diagnostics Market - Israel
      • 8.6.6.1. Israel: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.6.7. Covid-19 Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.6.8. Covid-19 Diagnostics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
  • 8.7. Covid-19 Diagnostics Market - Latin America
    • 8.7.1. Latin America: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.7.4. Covid-19 Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.7.5. Covid-19 Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.7.6. Covid-19 Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
    • 8.7.7. Covid-19 Diagnostics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Roche Diagnostics
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Thermo Fisher Scientific
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BioMerieux
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. PerkinElmer
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Danaher Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Quidel Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Hologic
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Becton Dickinson
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Cepheid
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Grifols
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Stryker Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Zhejiang Orient Gene Biotech
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. BGI Genomics
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제